ESMO Lifetime Achievement Award

The Dutch Cancer Institute (NKI) has won the ESMO Lifetime Achievement Award, presented by The European Society for Medical Oncology, for its `excellent translational research into breast cancer´.

Photo: ESMO Lifetime Achievement Award

The NKI has bridged the field of molecular biological research and the clinic. In particular it has developed genetic assays for breast cancer that, according to ESMO, lead to better understanding of the disease and probably to more precise and less aggressive treatment.
The ESMO award – which includes ?50,000 for research - was presented for the second time; last year it went to the Breast International Group (BIG), a platform for clinical research into breast cancer.

Apologies instead of condolences
The wife of a patient, who had been treated in the ICU of the Medisch Spectrum Twente Hospital after receiving serious burns during a barbecue accident, received a questionnaire asking her to tell the hospital management about her experience with condolences she had received. The hospital letter arrived just as her husband arrived home. Its opening sentence read: ‘Recently your husband died in the intensive care ward….’ The hospital offered its apologies … better than condolences!

31.08.2007

More on the subject:

Related articles

Photo

News • Microbiome map reveals complex interactions

Frenemies in the gut: how bacteria help and hinder each other

A new study sheds light on the complex competition and cooperation between bacteria in the gut microbiome. These insights could be leveraged for targeted manipulation of the microbiome.

Photo

News • Bloodstream infections

Rethinking bacterial culturing to accelerate sepsis diagnostics

Using a specialized “broth”, researchers have developed a way to condense the days-long diagnosis timeline for sepsis to just hours, facilitating faster diagnosis and clinical decision-making.

Photo

News • Biphasic drug delivery system

3D-printed microneedle patch could improve skin cancer treatment

This small patch contains tiny microneedles that can gently pass through the outer layer of the skin without drawing blood, to deliver two anti-cancer drugs for localised skin cancer treatment.

Subscribe to Newsletter